Thank you for visiting the Injury Lawsuit ” website. Balkin & Eisbrouch, LLC created Injury Litigation News to inform visitors about the dangers associated with dangerous drugs and defective products, as well as legal developments and services provided by Balkin & Eisbrouch in connection with such products. This website is provided for informational purposes only. The information is not guaranteed to be correct, complete, or current. We make no warranty, expressed or implied, about the accuracy or reliability of the information at this website or at any other website to which this site is linked.
None of the information offered on the website is intended as legal advice, nor does it constitute legal advice. Whether visitors are in need of legal services is a personal and important decision that should not be based on the information contained on websites.
The information presented is not intended to create an attorney-client relationship between Balkin & Eisbrouch, LLC and visitors to the website. The only way to become our client is through a mutual agreement in a formal letter indicating that we have accepted your case. Requesting a free case evaluation will not create an attorney-client relationship.
Balkin & Eisbrouch, LLC has tried to comply with all legal and ethical requirements in compiling this website. This website is not soliciting clients, does not propose any type of transaction, nor does it guarantee any case results.
Balkin & Eisbrouch, LLC practices in federal district courts throughout the United States. Members of the firm are licensed to practice in Illinois, Colorado, New York, New Jersey, Washington DC, and Wisconsin. We also affiliate with attorneys licensed to practice in almost every state court in the United States.
To the extent that the professional responsibility rules of any jurisdiction require designation of a principal office or an attorney responsible for this website, Balkin & Eisbrouch, LLC designates its office at 50 Main Street, Suite 6, Hackensack, NJ, and its managing partner, David Eisbrouch.